AbdullahKhanMD

Hematology • Columbus, OH

Hematologic Oncology

Assistant Professor, Division Of Hematology

Join to view full profile

Dr. Khan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Khan's full profile

Already have an account?

Office
460 W 10th Ave
Columbus, OH 43210
Phone+1 614-293-3196

Fax+1 614-293-4812

Education & Training

Aga Khan Medical CollegeClass of 2010
University of FloridaFellowship, Hematology and Medical Oncology
Hackensack University Medical CenterResidency, Internal Medicine

Certifications & Licensure

NY State Medical License 2011 - 2026
OH State Medical License 2018 - 2026
FL State Medical License 2015 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma Start of enrollment: 2021 Sep 27
Terminated
Phase 1
Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies Start of enrollment: 2023 Dec 21
Recruiting
Phase 1
Roles: Sponsor-Investigator, Contact, Principal Investigator

Publications & Presentations

PubMed

9 citations
Fitness and frailty in myeloma.
Charlotte Pawlyn, Abdullah M Khan, Ciara L Freeman
Hematology. American Society of Hematology. Education Program. 2022-12-09
9 citations
Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features.
Abdullah M Khan, Jameel Muzaffar, Hermant Murthy, John R Wingard, Jan S Moreb
Case Reports in Hematology. 2018-01-01
2 citations
Outcomes After Salvage Autologous Hematopoietic Cell Transplant for Patients With Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience.
Abdullah M Khan, Michael Ozga, Harshil Bhatt, Muhammad S Faisal, Sadia Ansari
Clinical Lymphoma, Myeloma & Leukemia. 2023-03-01